Shareholders claim Vertex Pharmaceuticals inflated its share price by failing to disclose adverse information about its experimental hepatitis C drug, VX-950 (telaprevir), in Boston Federal Court.
Shareholders accuse directors of Candela Corp. or wasting corporate assets and breaching fiduciary duties, in Middlesex County Court, Woburn, Mass.
Shareholders accuse Familymedsgroup of wasting more than $80 million in corporate assets, in Hartford Superior Court.
Read the Top 8
Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.
Additional Reads
-
-
Judge advances Bayer shareholder class action over Monsanto merger October 19, 2021
-
-
Pay Day Lender Faces RICO Suit in Rent-a-Tribe Class Action April 13, 2020